HPV Screening Recommendations

Screening Strategy by Age Group

The American Cancer Society recommends that HPV testing combined with Pap testing (cotesting) should begin at age 30 years, not before, due to the higher specificity in this age group reducing false-positives while maximizing cancer prevention 1, 2
For women aged 21-29 years, Pap testing alone every 3 years is the appropriate screening method, as HPV prevalence is substantially higher in younger women, leading to excessive false-positives and unnecessary colposcopies without improving cancer prevention 1, 2, 3
In women aged 25-29 years, HPV testing may only be used for triage of abnormal Pap results, specifically ASC-US, and not for primary screening 3
For women aged 30-65 years, cotesting (HPV + Pap) every 5 years is the preferred strategy, although primary HPV testing alone every 5 years is an acceptable alternative 1, 2, 6
The American College of Obstetricians and Gynecologists (ACOG) endorses cotesting as an acceptable approach for women 30-65 years 4, 5

For post-hysterectomy women (with cervix removed) who had the procedure for benign reasons, all screening should be discontinued 4, 5, 7
Immunocompromised or HIV-positive women may require more frequent screening intervals 4, 5
Women with a history of high-grade lesions should continue screening for at least 20 years, even beyond age 65 7

Primary HPV testing shows superior sensitivity compared to cytology alone across all age groups, but the benefit-to-harm ratio only becomes favorable at age 30 and above, with a 51% higher detection of high-grade lesions at enrollment and a 42-47% reduction in subsequent detection 1, 2